REGULATED PRESS RELEASE published on 11/04/2025 at 07:01, 1 month 18 days ago bioMérieux – Information financière du 3ème trimestre 2025 bioMérieux communique ses informations financières pour le 3ème trimestre 2025. Croissance organique de +7,3% atteignant 2 992M€. Objectifs 2025 confirmés malgré contexte, chiffre d'affaires par application et région détaillé Chiffre D'affaires BioMérieux Croissance Organique Objectifs 2025 3ème Trimestre
REGULATED PRESS RELEASE published on 11/04/2025 at 07:01, 1 month 18 days ago bioMérieux – Third-Quarter 2025 Business Review bioMérieux reports 7.3% organic sales growth in the first nine months of 2025, meeting annual guidance. Sales reach €2,992m driven by strategic plans. Full-year guidance updated Financial Results BioMérieux Strategic Plan Organic Sales Growth Full-year Guidance
PRESS RELEASE published on 11/04/2025 at 07:00, 1 month 18 days ago AT&S continues upward trend and exceeds forecast AT&S continues upward trend and exceeds forecast for H1 2025/26 with revenue reaching €846 million, EBITDA margin at 20.6%, and forecasted revenue of €1.7 billion for FY 2025/26 EBITDA Revenue Forecast AT&S Upward Trend
PRESS RELEASE published on 11/04/2025 at 07:00, 1 month 18 days ago Nordex Group delivers strong 3Q/2025 performance with significant margin expansion and robust free cash flow Nordex Group reports strong 3Q/2025 performance with increased EBITDA and cash flow. Full-year EBITDA margin guidance raised. Order intake and net income show growth EBITDA Cash Flow Order Intake Nordex Group 3Q/2025 Performance
PRESS RELEASE published on 11/04/2025 at 07:00, 1 month 18 days ago Nemetschek Group continues its very strong and profitable growth in Q3 2025 and reconfirms its updated guidance for the full year 2025 Nemetschek Group reports strong growth and reconfirms guidance for 2025, with revenue up 20.0% in Q3 to EUR 293.1 million. EBITDA increases to EUR 95.2 million, showing a margin improvement to 32.5% EBITDA Revenue Growth Nemetschek Group 2025
PRESS RELEASE published on 11/04/2025 at 07:00, 1 month 18 days ago Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate Valneva SE reports positive Phase 1 trial results for VLA1601, its second-generation Zika vaccine candidate, showing improved immune response. Safety and immunogenicity demonstrated in trial Phase 1 Trial Valneva SE Safety Immunogenicity Zika Vaccine
PRESS RELEASE published on 11/04/2025 at 07:00, 1 month 18 days ago Valneva annonce des résultats positifs de Phase 1 pour son candidat vaccin de deuxième génération contre le virus Zika Valneva annonce des résultats positifs de phase 1 pour son candidat vaccin de deuxième génération contre le virus Zika, montrant une réponse immunitaire améliorée Valneva Immunitaire Phase 1 Vaccin Zika
PRESS RELEASE published on 11/04/2025 at 06:30, 1 month 18 days ago Ad hoc announcement pursuant to Art. 53 LR News Release Oerlikon reports a good performance in Q3 2025 despite challenges in end markets. Order intake increased by 11% and sales by 3% at constant FX. Strategic efficiency measures in place Sales Order Intake Performance Oerlikon Q3 2025
PRESS RELEASE published on 11/04/2025 at 06:05, 1 month 18 days ago Cognizant Adopts Anthropic's Claude to Accelerate Enterprise AI Adoption at Scale and Deploys Claude to Drive Internal AI Transformation Cognizant adopts Anthropic's Claude for enterprise AI adoption at scale and internal AI transformation, combining large language models with engineering platforms Technology Partnership AI Adoption Cognizant Anthropic's Claude Enterprise Scale
PRESS RELEASE published on 11/04/2025 at 05:00, 1 month 18 days ago ADTRAN Holdings, Inc. reports third quarter 2025 financial results ADTRAN Holdings, Inc. reports 23% year-over-year revenue growth and strategic focus on sustainable growth for Q3 2025 Revenue Growth Strategic Focus Financial ADTRAN Holdings Third Quarter Results
Published on 12/22/2025 at 23:35, 3 hours 15 minutes ago Cypher Metaverse Inc. Announces Closing of Financing
Published on 12/22/2025 at 23:05, 3 hours 45 minutes ago BlackBerry to Host Investor Briefing at CES 2026
Published on 12/22/2025 at 22:50, 4 hours ago American Critical Minerals Clarifies Technical Disclosure
Published on 12/22/2025 at 22:35, 4 hours 15 minutes ago NioCorp to Begin Construction of Mine Portal at Its Elk Creek Critical Minerals Project
Published on 12/22/2025 at 22:02, 4 hours 48 minutes ago Unusual Machines Receives Initial Order from Performance Drone Works for $3.75 Million as Part of a Strategic Supplier Relationship
Published on 12/23/2025 at 00:15, 2 hours 35 minutes ago FINALS, SEMI-FINALS AND NON-STOP ACTION AS GOTF 2025 REACHES CLIMAX
Published on 12/22/2025 at 22:05, 4 hours 45 minutes ago mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
Published on 12/22/2025 at 21:36, 5 hours 14 minutes ago Revolution Wind and Sunrise Wind receive lease suspension orders from US Department of the Interior’s Bureau of Ocean Energy Management
Published on 12/22/2025 at 20:16, 6 hours 33 minutes ago EQS-Adhoc: PIERER Mobility AG (to be renamed soon to Bajaj Mobility AG): CEO Gottfried Neumeister confirmed until the end of 2028
Published on 12/22/2025 at 18:33, 8 hours 17 minutes ago ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 8 hours 45 minutes ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 18:05, 8 hours 45 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Published on 12/22/2025 at 17:45, 9 hours 5 minutes ago Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Published on 12/22/2025 at 17:35, 9 hours 15 minutes ago DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025